Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$1.4 - $2.41 $4 - $7
3 New
3 $0
Q2 2023

Aug 14, 2023

BUY
$2.42 - $4.04 $9,324 - $15,566
3,853 Added 103.69%
7,569 $22,000
Q1 2023

May 09, 2023

BUY
$2.77 - $5.49 $3,556 - $7,049
1,284 Added 52.8%
3,716 $11,000
Q4 2022

Feb 10, 2023

SELL
$4.5 - $5.72 $1,030 - $1,309
-229 Reduced 8.61%
2,432 $13,000
Q3 2022

Nov 10, 2022

BUY
$3.77 - $6.39 $10,020 - $16,984
2,658 Added 88600.0%
2,661 $11,000
Q2 2022

Aug 15, 2022

BUY
$3.8 - $6.08 $11 - $18
3 New
3 $0
Q1 2022

May 12, 2022

SELL
$3.64 - $6.49 $433 - $772
-119 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$5.06 - $6.69 $49,218 - $65,073
-9,727 Reduced 98.79%
119 $1,000
Q3 2021

Nov 15, 2021

BUY
$5.14 - $13.22 $41,407 - $106,500
8,056 Added 450.06%
9,846 $61,000
Q2 2021

Aug 16, 2021

BUY
$6.02 - $12.91 $10,775 - $23,108
1,790 New
1,790 $11,000
Q1 2021

May 17, 2021

SELL
$8.84 - $17.0 $2,819 - $5,423
-319 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$6.15 - $18.7 $1,961 - $5,965
319 New
319 $5,000

Others Institutions Holding IPA

About ImmunoPrecise Antibodies Ltd.


  • Ticker IPA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,836,700
  • Market Cap $10.2M
  • Description
  • ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...
More about IPA
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.